The Development of a Platform Designed to Activate NK Cells
November 11th 2021Jeffrey Miller, MD, discusses the background of the Tri-Specific Killer Engager TRICK platform for the activation of natural killer cells for the treatment of refractory tumors, including those that are hematology-based.
Watch